СOVID-19 Alert!

With global travel restrictions, we are arranging online medical consultations with best medical centers as well as pre-bookings for future medical treatments. Explore Now… Go Later. Continue your healthcare journey.

Dr. Marco Colleoni

Dr. Marco Colleoni, Oncology & Experimental Endocrinology Specialist

Milan, Italy

Milano, Via Ripamonti, 435 (Building 1)

Speciality: Oncology & Experimental Endocrinology Specialist

Languages: Italian, English

Degree: Medical Oncologist

About - Dr. Marco Colleoni


1989 - 1991 - Istituto Nazionale dei Tumori  - Medical Oncologist MD fellow – Division of Medical Oncology B
1991 - 1993 - Istituto Nazionale dei Tumori  - Medical Oncologist - MD Associate researcher – Division of Medical Oncology B
1993 - 1996  - Castelfranco Veneto City Hospital - Medical Oncologist and Deputy Director – Division of Medical Oncology
1996 - 1998  - Istituto Europeo di Oncologia  - Medical Oncologist  - Senior Assistant – Division of Medical Oncology
1998 - 2001 - Istituto Europeo di Oncologia (IEO) - Medical Oncologist - Deputy-Director - Division of Medical Oncology
2001 - 2005 - Istituto Europeo di Oncologia (IEO)  - Medical Oncologist  - Co-Director - Division of Medical Oncology
2005 - 2013 - Istituto Europeo di Oncologia (IEO) - Medical Oncologist  - Direttore -  Unità di Ricerca in Senologia Medica
01/02/2013 - present - Istituto Europeo di Oncologia (IEO)  - Medical Oncologist - Director - Division of Medical Senology


Director of the Division of Medical Senology to lead the area of medical treatment of Breast Cancer at the IEO, creating and conducting a structure for excellence in patient care. Ten Physicians are currently involved in care and research at the Division of Medical Senology.

The area of Medical Senology is aimed to provide comprehensive care of all the types and phases (preoperative, adjuvant, advanced disease) of breast cancer with active clinical and translational research, integrating outpatient and in-patient areas through a common support. The principle of providing the best personalized care for the individual patient with breast cancer, with full respect for quality of life and proper communication, is the best support for competitive and innovative clinical research.

During the past 3 years a significant increase in the number of Patients followed in the Day Hospital (from 2918 in 2011 to 4840 in the first eleven months of 2013) as well as in the out-patient clinic was registered (from 3593 in 2011 to 5209 in the first eleven months of 2013). He is in charge for the care of the patients treated within the in-patient clinic (8 patients per week). He is the

Director of the weekly multidisciplinary meeting on early breast cancer where approximately 50-60 patients are discussed every week. During the first 11 months of 2013 he planned the medical adjuvant treatment of 2314 patients.


Direct responsibility in research programs directed to develop personalized and innovative treatment plans for all the phases of the disease based on individual needs and biological features of the tumor. Research programs are dedicated also to specific aspects of breast cancer such as special histological types, inflammatory breast cancer, and very young patients. During the past 3 years he served as principal investigator in 52 phase I-III studies on breast cancer. He is member of the Steering Committee of 4 International Studies.

As Co-Chairman of the Scientific Committee of the International Breast Cancer Study Group (IBCSG) he is Coordinator of several cooperative  trials. These Trials are conducted with the active cooperation of the IEO with more than 2000 patients included in past and ongoing studies.

The IBCSG is a cooperative group, which conducts large, multicenter, randomized trials. It is dedicated to innovative clinical research designed to improve the prognosis of women with operable breast cancer. Patients and investigators from twenty countries in five continents (Europe, Australia/New Zealand, Africa, Asia, and North America) are involved in this cooperation. The IBCSG has been a pioneer in research into combined hormonal therapy and chemotherapy, timing and duration of adjuvant therapies, and the assessment  of quality of life of breast cancer patients. Since 1978, 32.865 patients with breast cancer have been enrolled in randomized clinical trials and are included in IBCSG databases. The group has published 285 publications focusing on various aspects of breast cancer treatment (I.F. 2011 186.53 – I.F. 2012 165.025).

When developing trials, the IBCSG follows some basic principles:

  • Research questions are based upon biological hypotheses
  • Trials complement each other, thus allowing information from separate  programs to be combined to address common research questions
  • All research questions should be selected for their direct impact on patient care

In addition to the clinical trials research questions, the IBCSG carries out extensive research in pathology, database studies, quality of life, and statisticalmethodology (together with the Harvard Medical School and Dana-Farber Cancer Institute, Boston MA, USA).

He is author of approximately 300 publications in peer-reviewed journals.



Education - Dr. Marco Colleoni

1987: University of Milan; University Degree in Medicine
1991: University of Milan; Specialization degree in Oncology (70/70)
1994: University of Milan; Specialization degree in Experimental Endocrinology (70/70)

Memebership - Dr. Marco Colleoni

Director of the Division of Medical Senology at Istituto Europeo di Oncologia (IEO), Milan, Italy
  • Executive Committee of IEO Education
  • Milan Breast Cancer Conference Scientific  Secretary (MBCC)
  • Early Breast Cancer Trialists Group, Oxford
  • Commissione Scientifica Ministero della Salute ESMO Guidelines Task Force
  • Ethics Committee of Istituto Nazionale Tumori, Milano
  • Foundation Council International Breast  Cancer Study Group (IBCSG)
  • St Gallen International Cancer Conference  Expert Panel
  • Breast International Group (B.I.G)
  • Co-Chair, International Breast Cancer Study Group (IBCSG)

Costs of Cancer Treatment procedures in Milan, Italy



Bladder Cancer in Milan, Italy$43703Enquire
Colon Cancer in Milan, Italy$32400Enquire
Kidney Cancer in Milan, Italy$47470Enquire
Lung Cancer in Milan, Italy$38400Enquire
Prostate Cancer in Milan, Italy$16980 - $46717Enquire

Popular Medical Centers

Dr. Choy's PLDD treatment method is used by Dr. Gian Paolo Tassi in Italy where he has successfully performed the procedure on hundreds of patients. PLDD is synonim with Dr. Gian Paolo Tassi's in Italy. Being the only accredited specialist to use this method in the peninsula, in cities such as Rome, but mainly San Benedetto del Tronto in Marche region, in Italy.
Mahrukh Hassan

Prompt response!

View More
  • from $11000
  • from $8000
  • from $25000
  • from $20000
Stand Up Prosthetic Urology Center of Excellence for Penile Implants is located at the heart of Gangnam, also known as the Beverly Hills of South Korea. Our state of the art facility consists of an outpatient office, 2 OR rooms, a sterilizing room, as well as several recovery rooms. We are also proud to host our very own American patient liaison, who is always available to meet any and all of

Very understanding and careful surgeon, Dr Sean made me feel at ease, and relaxed.

View More
  • Circumcision from $1000
  • Male Erectile Urology Procedures from $14800
  • Urology from $15800
  • Vasectomy from $1000
  • Penile Augmentation from $3500
We shape your desire ... Live it with passion ... ! Ruby® Surgery & Aesthetics is a premier plastic surgery center located in Guadalajara, Mexico. Our center is headed by Ruben Agredano Jimenez, MD one of the best Board certified plastic surgeon of the country. Our team of QUALIFIED and BOARD CERTIFIED professionals specialize in facial surgery & minimally invasive procedures, body contourin
Marnie R Simmonds

Friendly, helpful. I would not go to anyone else given the choice

View More
  • Eyelid Surgery from $2000
  • Forehead Contouring from $2300
  • Abdominal Etching from $2300
  • Tummy Tuck Surgery from $3000
  • Mini Abdominoplasty from $2300
  • Brachioplasty from $2300
MAXIM Hair Restoration is a top clinic for hair transplant and hair restorations in Legaspi Village, Makati, Metro Manila, Philippines. The clinic provides top-class surgical and non-surgical hair loss solutions including FUE, FUT, PRP, SMP, Cosmetic Surgery, etc.
  • Follicular Unit Transplantation FUT from $1830
  • Follicular Unit Extraction FUE from $2780
  • Platelet Rich Plasma PRP for Hair from $2170
Bypass Gástrico Mérida, located in Merida, Mexico, offers a wide range of obesity and diabetes using cutting-edge technology. The health professionals here are known to treat patients from all over the world at affordable packages.
  • Roux en Y Gastric Bypass from $7500
  • Sleeve Gastrectomy from $5100
  • Mini Gastric Bypass from $6800
  • Duodenal Switch Surgery from $9000
  • Gastric Balloon from $2900
  • Lap Band Surgery from $5300
Sani Dental Group is one of the biggest dental service providers in Playa del Carmen, Mexico with approvals of the Medical Tourism Association and the American Dental Association (ADA). Get the best Bone Graft/Sinus Lift, Cosmetic Dentistry, Crowns, Dental Implants, Dental Laser, Veneers, Dentures, Full Mouth Restoration and Zygomatic Implants in Playa del Carmen, Mexico.
Make Appointment Center Details Chat With Us


Doctor Rating

Not yet reviewed, be the first to write a review.

PlacidWay.com provides information and travel related services. We do not provide health care services. We provide information solely for informational purposes and do not endorse any particular health care provider or facility or any particular health care service or treatment. We are not affiliated with any health care provider or service and we are not responsible for any health care service. Please consult with your own domestic licensed health care provider before seeking the services of any health care provider you learn about via our site.

Free Call